|
|
|
| |
|
|
| |
The latest drug discovery news from News Medical |
|
|
|
 | | |
 Practical guide to DILI assessment
Drug-induced liver injury remains one of the most significant safety challenges in drug development. This technology guide explores how liver microphysiological systems help de-risk safety assessment, investigate DILI mechanisms, and generate human-relevant insight. Includes practical implementation considerations and emerging regulatory perspectives.
| |
|
|
|
 | | |
| |
|
 What Metabolomics Can Reveal for Drug Discovery
Metabolomics is providing drug discovery researchers with a deeper view of disease biology and therapeutic response. This eBook explores how untargeted metabolomics, lipidomics, and multi-omics can uncover biological pathways, identify biomarkers, investigate mechanisms of action, and support patient stratification, helping translate complex molecular data into meaningful therapeutic insights.
|
|
| | | | |
| |
|
![[Free Webinar] When discovery metabolomics becomes quantitative](https://www.azonetwork.com/newsletters/images/generic/115__639245511077206567_multisizecolor_0_custom.jpg) [Free Webinar] When discovery metabolomics becomes quantitative
Traditional omics workflows often separate discovery and quantitation into distinct experiments. Researchers first perform untargeted analyses to identify molecules of interest, then develop targeted methods to accurately quantify those findings. But what if discovery data was already quantitative?
In this webinar, Paul Baker will explore how ZT Scan DIA is helping bridge the gap between untargeted discovery and quantitative analysis. Through real-world examples, discover how ZT Scan DIA is transforming discovery data into a long-term quantitative asset.
|
|
| |
|
|
|
| | |  Mitochondria - tiny structures that convert nutrients into energy - are often depicted as discrete kidney bean-shaped objects. | | | | | __639264406201623531_multisizecolor_150_custom.jpg) New York University researchers have trained an AI model to learn chemical patterns associated with stability in drug-like molecules and accurately predict where their hydrogen atoms should be positioned. | | | | |  The ocean contains diverse carbohydrates that could serve as valuable resources for drug development. Algae, marine animals and microorganisms produce polysaccharides and related molecules with structures that are uncommon on land, including distinctive sulfate patterns, sugar linkages and branched architectures. | | | | | __639264406328283662_multisizecolor_150_custom.jpg) Critical Path Institute (C-Path) today announced that its Translational Therapeutics Accelerator has awarded $1,699,500 through five Bridging Research and Innovation in Drug Development Grants (BRIDGe). | |
|
|
|
| | How would you rate today's newsletter?
| |
|
|
|
| | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
